South Russian Journal of Cancer. 2024. Vol. 5, No. 2. P. 35-42
4.0
https://doi.org/10.37748/2686-9039-2024-5-2-4
https://elibrary.ru/mfunss
South Russian
ORIGINAL ARTICLE
Journal of Cancer
Южно-Российский
онкологический журнал
Vol. 5
Hypoxia effect on proliferative activity of cells in orthotopic No. 2, 2024
xenograft of hepatocellular carcinoma of the liver in the
experiment
T. M. Kecheryukova1, V. S. Trifanov1,2, A. A. Shulga1, A. S. Goncharova1, S. V. Gurova1, E. P. Ulyanova1, A. Yu. Maksimov1
1 National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation 2 P. A. Hertsen Moscow Oncology Research Institute – Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, Moscow, Russian Federation
ABSTRACT
Purpose of the study. The purpose of this research was to investigate the effect of in vivo hypoxic conditions on the proliferative potential of HepG2 liver cancer cells.
Materials and methods. Human liver cancer cells of the HepG2 line have been cultured. The HepG2 cell suspension was injected subcutaneously into mice in an amount of 5 × 106 to obtain a xenograft. Tumor nodes that had reached the required size were divided into fragments and transplanted into the orthotopic site. Balb/c nude mice with implanted HepG2 liver cancer xenograft were used in this experiment. The mice with tumor implanted in the liver were divided into two groups, intact and hypoxic. Mice from the second group underwent liver blood flow reduction by occlusion of the portal triad for 20 minutes.
Tumor nodes were extracted for histological and immunohistochemical staining for proliferation marker Ki-67 on the 4th day after the procedures. The proportion of positively stained cells was calculated, and the results were statistically analyzed using the Statistica 10.0 software.
Results. Orthotopic models of liver cancer in Balb/c Nude mice were obtained. Histological and immunohistochemical studies were carried out. Histological analysis showed that hepatocellular carcinoma is characterized by an average degree of differentiation. In the tissues of these xenografts, by using immunohistochemical analysis for the proliferation marker Ki-67, it was possible to identify statistically significant differences between the two groups, i. e. intact and the one with reduction of blood flow. The proportion of immunopositive cells was 65 [65–70] % and 19 [15–25] %, respectively.
Conclusion. A tendency to decreased proliferative activity of tumor cells after hepatic blood flow reduction, i. e. hypoxia exposure, was demonstrated. Our data indicate that the proliferative activity of tumor cells is directly related to the microenvironment, and to the hypoxic environment in particular. Further study of the effect of hypoxia on the processes of growth and development of malignant tumors may contribute to a deeper understanding of the biological features of tumors and their treatment.
Keywords: hypoxia, liver, HepG2, proliferation, Ki-67, in vivo For citation: Kecheryukova T. M., Trifanov V. S., Shulga A. A., Goncharova A. S., Gurova S. V., Ulyanova E. P., Maksimov A. Yu. Hypoxia effect on proliferative activity of cells in orthotopic xenograft of hepatocellular carcinoma of the liver in the experiment. South Russian Journal of Cancer.
2024; 5(2): 35-42. https://doi.org/10.37748/2686-9039-2024-5-2-4, https://elibrary.ru/mfunss For correspondence: Anna A. Shulga – junior researcher at the Testing Laboratory center, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
Address: 63 14 line str., Rostov-on-Don 344037, Russian Federation E-mail: [email protected]
ORCID: https://orcid.org/0009-0006-1125-2897
SPIN: 6457-4451, AuthorID: 1221869
Compliance with ethical standards: when performing this study, all manipulations with laboratory animals were carried out in compliance with the Rules and Regulations for Carrying Out Animal Research Work. The study was approved by the Ethics Committee of the National Medical Research Center for Oncology (Protocol No. 4/108 dated 02/10/2021)
Funding: this work was not funded
Conflict of interest: the authors declare that there are no obvious and potential conflicts of interest associated with the publication of this article The article was submitted 08.11.2023; approved after reviewing 08.04.2024; accepted for publication 09.05.2024
© Kecheryukova T. M., Trifanov V. S., Shulga A. A., Goncharova A. S., Gurova S. V., Ulyanova E. P., Maksimov A. Yu., 2024
35
Южно-Российский онкологический журнал. 2024. Т. 5, № 2. С. 35-42
https://doi.org/10.37748/2686-9039-2024-5-2-4
https://elibrary.ru/mfunss
3.1.6. Онкология, лучевая терапия
ОРИГИНАЛЬНАЯ СТАТЬЯ
Влияние гипоксии на пролиферативную активность клеток ортотопического
ксенографта гепатоцеллюлярной карциномы печени в эксперименте
Т. М. Кечерюкова1, В. С. Трифанов1,2, А. А. Шульга1, А. С. Гончарова1, С. В. Гурова1, Е. П. Ульянова1, А. Ю. Максимов1
1 ФГБУ «Национальный медицинский исследовательский центр онкологии» Министерства здравоохранения Российской Федерации, г. Ростов-на-Дону, Российская Федерация
2 Московский научно-исследовательский онкологический институт им. П. А. Герцена – филиал ФГБУ «Национальный медицинский
исследовательский центр радиологии» Министерства здравоохранения Российской Федерации, г. Москва, Российская Федерация
РЕЗЮМЕ
Цель исследования. Оценить пролиферативную активность клеток рака печени HepG2 при моделировании гипок-сических условий in vivo.
Материалы и методы. Культивировали клетки рака печени человека линии HepG2. Для получения ксенографта клеточ-ную суспензию HepG2 вводили мышам подкожно в количестве 5 × 106. Достигшие необходимого размера опухолевые
узлы делили на фрагменты и трансплантировали в ортотопический сайт. В работе использовали мышей линии Balb/c Nude, которым имплантировали ксенографт рака печени HepG2. Мышей с прижившейся опухолью в печени делили
на две группы – интактная и с гипоксией. Мышам из второй группы выполняли редукцию кровотока печени путем
окклюзии портальной триады в течение 20 мин. На 4-е сутки после проведенных манипуляций опухолевые узлы
извлекали для выполнения гистологического и иммуногистохимического окрашивания на маркер пролиферации
Ki-67. Вычисляли долю позитивно окрашенных клеток и проводили статистический анализ результатов с помощью
пакета программ Statistica 10.0.
Результаты. Были получены ортотопические модели рака печени у мышей линии Balb/c Nude. Проведены гисто-логическое и иммуногистохимическое исследования. Гистологический анализ показал, что гепатоцеллюлярная
карцинома характеризуется средней степенью дифференцировки. В тканях данных ксенографтов с помощью иммуногистохимического анализа на маркер пролиферации Ki-67 удалось выявить статистически значимые различия
между двумя группами – интактной и с редукцией кровотока. Доля иммунопозитивных клеток составила 65 [65–70]
% и 19 [15–25] % соответственно.
Заключение. Продемонстрирована тенденция к снижению пролиферативной активности опухолевых клеток после
редукции кровотока печени, то есть воздействия гипоксии. Полученные нами данные свидетельствуют о том, что
пролиферативная активность клеток опухоли напрямую связана с микроокружением, в частности, с гипоксической
средой. Дальнейшее изучение воздействия гипоксии на процессы роста и развития злокачественных образований
может способствовать более глубокому пониманию биологических характеристик опухолей и их лечения.
Ключевые слова: гипоксия, печень, HepG2, пролиферация, Ki-67, in vivo Для цитирования: Кечерюкова Т. М., Трифанов В. С., Шульга А. А., Гончарова А. С., Гурова С. В., Ульянова Е. П., Максимов А. Ю. Влияние
гипоксии на пролиферативную активность клеток ортотопического ксенографта гепатоцеллюлярной карциномы печени в эксперименте.
Южно- Российский онкологический журнал. 2024; 5(2):35-42. https://doi.org/10.37748/2686-9039-2024-5-2-4, https://elibrary.ru/mfunss Для корреспонденции: Шульга Анна Александровна – младший научный сотрудник испытательного лабораторного центра, ФГБУ
«Национальный медицинский исследовательский центр онкологии» Министерства здравоохранения Российской Федерации, г. Ростов-на- Дону, Российская Федерация
Адрес: 344037, Российская Федерация, г. Ростов-на- Дону, ул. 14-я линия, д. 63
E-mail: [email protected]
ORCID: https://orcid.org/0009-0006-1125-2897
SPIN: 6457-4451, AuthorID: 1221869
Соблюдение этических стандартов: при выполнении данного исследования все манипуляции с лабораторными животными проводились
в соответствии с «Правилами проведения работ с использованием экспериментальных животных». Исследование одобрено этическим
комитетом ФГБУ «Национальный медицинский исследовательский центр онкологии» Министерства здравоохранения Российской
Федерации (протокол № 4/108 от 10.02.2021 г.)
Финансирование: финансирование данной работы не проводилось
Конфликт интересов: все авторы заявляют об отсутствии явных и потенциальных конфликтов интересов, связанных с публикацией
настоящей статьи
Статья поступила в редакцию 08.11.2023; одобрена после рецензирования 08.04.2024; принята к публикации 09.05.2024
36
Южно-Российский онкологический журнал 2024. Т. 5, № 2. С. 35-42
Кечерюкова Т. М., Трифанов В. С., Шульга А. А., Гончарова А. С., Гурова С. В., Ульянова Е. П., Максимов А. Ю. Влияние гипоксии на пролиферативную
активность клеток ортотопического ксенографта гепатоцеллюлярной карциномы печени в эксперименте
INTRODUCTION
the features of their microenvironment.
The effect of the level of oxygenation is studied
The hypoxic environment, characterized by low
using various approaches, including in vitro, it is also oxygen content, plays a crucial role in the process-possible to use methods of isolated primary tumors,
es of cell survival and reprogramming. This fact is
but they do not accurately reflect the real parame-
confirmed by numerous studies on the evolution and
ters of the tumor microenvironment [11]. An analysis
development of organisms [1, 2]. Particularly, it has
of the literature data shows that the most reliable
been established that the normal development of
and trustworthy data can be obtained using in vivo
mammals occurs under conditions of hypoxia (mod-
methods that allow more accurately, compared with
erate to severe), which regulates many aspects of
other research approaches, to model the effect of
ontogenesis and morphogenesis. In addition, it is
hypoxia on the activity of malignant neoplasms and
known that the oxygen gradient is an important reg-
their proliferative potential, which may be important
ulator of cellular processes in both physiological and
for planning further translational studies [12, 13].
many pathological conditions, including malignant
The purpose of the study was to evaluate the
diseases [3].
proliferative activity of HepG2 liver cancer cells in
Sudden and short-term effects of hypoxia (from
modeling hypoxic conditions in vivo.
several minutes up to 72 hours), resulting from fluc-
tuations in tumor perfusion, are accompanied by
MATERIALS AND METHODS
functional and structural defects in the vascular
network of the tumor. Such exposure can lead to
Laboratory animals and their maintenance
the formation of high levels of reactive oxygen spe-
For this experiment, mice with Balb/c Nude immu-
cies (ROS), which can damage cells [4]. Hypoxia can
nodeficiency ( n = 14) 10–12 weeks old and weighing also cause the growth of cancer cells to stop, slow
25–27 g have been used and obtained from the vivar-
down proliferation and, subsequently, their death.
ium National Medical Research Center for Oncology,
It has been shown that hypoxia- induced factors di-
the Russian Federation Ministry of Health. The mice
rectly affect the proliferative activity of tumor cells
were in an IVC system (individually ventilated cages),
[5]. The most widely used marker of proliferation in
food and water were provided without restrictions.
both normal and tumor cells is the Ki-67 protein. It
All work with experimental animals was carried out in
participates in the cell cycle, being involved in ribo-
accordance with the ethical principle of the European
some biogenesis, heterochromatin organization and
Convention for the Protection of Vertebrates Used
mitotic chromosome separation [6]. The Ki-67 index
for Experiments or Other Scientific Purposes (ETSN
makes it possible to assess the degree of malignan-
123, Strasbourg, March 18, 1986). This experiment
cy of the tumor and predict the course of the disease
was approved by the decision of the local bioethical
in combination with other factors. A direct correla-
committee of the National Medical Research Center
tion has been established between the number of
for Oncology.
tumor cells expressing Ki-67 and the stage of malig-
nant diseases [7, 8]. The proliferative potential and
Culture of human liver cancer cells
survival of cancer cells can be modulated by creating
Human liver cancer cells of the HepG2 line were
hypoxic conditions, which is actively used in such
cultured in accordance with a standard procedure
therapeutic procedures as transarterial embolization
using a culture medium for DMEM cells with the ad-
and transarterial chemoembolization [9]. However,
dition of veal serum (Gibco, Thermo Fisher Scientific)
it is also known that hypoxia is crucial for the sur-
at a concentration of 10 %, as well as 1 % penicil-
vival of cells resistant to low-oxygen environments,
lin and streptomycin. Cultivation was carried out in
characterized by resistance to therapeutic effects
a CO incubator (Thermo Fisher Scientific, 8000W)
2
and increased invasive ability [10]. On this matter,
at a humid atmosphere of 37 °C, 5 % CO .2
a comprehensive study of the tumor's response to
hypoxia, as well as an understanding of its positive
Creating an orthotopic model of liver cancer
and negative effects, will expand the understanding
Initially, before conducting the experiment, we cre-
of the mechanisms of interaction of cancer cells and
ated a liver cancer xenograph by subcutaneously
37
South Russian Journal of Cancer 2024. Vol. 5, No. 2. P. 35-42
Kecheryukova T. M., Trifanov V. S., Shulga A. A., Goncharova A. S., Gurova S. V., Ulyanova E. P., Maksimov A. Yu. Hypoxia effect on proliferative activity of cells in orthotopic xenograft of hepatocellular carcinoma of the liver in the experiment injecting a 5 × 106 cell suspension of HepG2 into Bal-tions were made using a rotary microtome, which
b/c Nude mice ( n = 2). When the obtained subcutane-were subsequently dewaxed according to a standard
ous xenographs reached a diameter of 1–1.5 cm, the
protocol. Hematoxylin and eosin staining was per-
mice were euthanized, the tumor nodes were extract-
formed for histological examination. IHC staining
ed and divided into fragments about 1 × 1 × 1 mm in
was performed automatically in the BenchMark UL-
size for further transplantation into the liver. Access
TRA Ventana immunohistostainer according to the
to the liver was carried out by performing laparotomy
protocols of manufacturers attached to the antibod-
on pre-anesthetized recipient animals. An incision
ies used. Antibodies Ki-67 (clone SP6), CellMarque
was made in the left lobe of the liver, after which the
were used in a 1:200 dilution. To analyze the expres-
previously obtained tumor fragments were placed
sion of Ki-67 by tumor cells, the proportion of cells
into the parenchyma of the left lobe of the liver using
with colored nuclei (percentage of the total number
anatomical tweezers. The wound was sewn up with
of tumor cells) in at least 10 random fields of view
a wound stitch after the manipulations.
was calculated.
Creating hypoxic conditions by reducing liver
Statistical analysis
blood flow
The results obtained during the experiment were
A control laparotomy was performed to measure
analyzed using the Statistica 10.0 software package.
the volume of tumor nodes 2 weeks after the tumor
The data are presented in the form of the median,
fragments were implanted into the liver of mice. To
25th and 75th percentiles. A comparative analysis
determine the size of the tumor node, the following
of the differences in Ki-67 nuclear staining between
formula was used: V = LW2/2, L for the length of the
the groups was carried out with the Mann- Whitney
tumor, W for the width of the tumor. Then the animals statistical criterion.
were divided into 2 groups ( n = 6 for each), the distribution criterion was the size of the tumor node, while
STUDY RESULTS
the values of the average volume of tumor nodes in
the groups differed with a minimum interval. The
During the experiment, orthotopic models of liver
first group is intact, the second group is with a re-
cancer in Balb/c Nude mice were obtained by implant-
duction in liver blood flow. To provide access to the
ing a fragment of the xenograft of the HepG2 cell line
liver and its blood vessels, the mice of the second
directly into the left lobe of the liver [14]. A control
group underwent laparotomy. Then, to occlude the
laparotomy made it possible to demonstrate that all
vessels of the portal triad of the liver, a needle with
animals developed tumor nodes in the left lobe of the
suture material was inserted under them and blood
liver. The measurement results showed that 2 weeks
flow was reduced for 20 minutes using the tension
after implantation of the HepG2 xenograft fragment
of the suture material. After that, the tension of the
into the liver, the size of intrahepatic tumor nodes was
suture material was removed to restore blood supply
130.27 [42.88–345.3] mm3. (Fig. 1).
to the liver and the surgical wound was sutured in
After performing the control laparotomy proce-
layers. The mice of the first group underwent a con-
dure, the animals were divided into 2 groups. In or-
trol laparotomy without blood flow reduction.
der to induce hypoxic conditions, group 2 animals
underwent reduction of liver blood flow (Fig. 2). For
Euthanasia
this, the right lobe of the liver was shifted closer to
On the 4th day after the surgical manipulations,
the diaphragm, which facilitated free access to the
the animals were euthanized to extract tumor nodes.
portal triad. Clamping the vessels of the portal tri-
Euthanasia was performed by dislocation of the cer-
ad with suture material made it possible to achieve
vical vertebrae.
a reduction in the blood flow of the liver and the tu-
mor node located in it, which was visually confirmed
Histological and immunohistochemical (IHC)
by a change in the color of the liver, as a result of
studies
insufficient blood supply, the organ became paler.
The resulting tumor material was fixed in 10 %
After the restoration of blood supply, the liver turned
formalin for 24 hours, then enclosed in paraffin, sec-
maroon again.
38
Южно-Российский онкологический журнал 2024. Т. 5, № 2. С. 35-42
Кечерюкова Т. М., Трифанов В. С., Шульга А. А., Гончарова А. С., Гурова С. В., Ульянова Е. П., Максимов А. Ю. Влияние гипоксии на пролиферативную
активность клеток ортотопического ксенографта гепатоцеллюлярной карциномы печени в эксперименте
The results of histological examination showed
itive cells was 65 [65–70] % (Fig. 4A), in the group
a focus of hepatocellular carcinoma in the liver tis-
with blood flow reduction, the number of stained nu-
sues, characterized by an average degree of differ-
clei was statistically significantly less, which amount-
entiation, represented by solid- trabecular structures,
ed to 19 [15–25] % ( p < 0.001) (Fig. 4B).
in the thickness of which the vessels are located.
Necrosis foci are locally present. The cellular com-
DISCUSSION
position is represented by large epithelial cells re-
sembling hepatocytes. Large polymorphic nuclei with
It is known that hypoxia is an important factor that
granular chromatin and well-distinguishable nucleoli
can contribute to the formation of cellular plasticity
are visible inside the cells. Mitosis figures are also
and tumor heterogeneity, affecting the phenotype
found, including atypical forms (Fig. 3).
and cell functions. However, despite the impressive
In the immunohistochemical study of the expres-
array of data presented in the scientific literature, it
sion of the Ki-67 proliferation marker in the tissues of
is possible to observe a lack of correlation between
liver cancer xenographs, the number of immunopos-
different methods of studying the effect of oxygen
Fig. 1. Measurement of a tumor in the liver of a mouse
Fig. 2. The process of performing liver blood flow reduction by occlusion of the portal triad to induce hypoxic conditions А
Б
Fig. 3. Histological specimen: morphological picture of hepatocellular carcinoma. A – without hypoxia; B – after hypoxia. Magnification × 100
39
South Russian Journal of Cancer 2024. Vol. 5, No. 2. P. 35-42
Kecheryukova T. M., Trifanov V. S., Shulga A. A., Goncharova A. S., Gurova S. V., Ulyanova E. P., Maksimov A. Yu. Hypoxia effect on proliferative activity of cells in orthotopic xenograft of hepatocellular carcinoma of the liver in the experiment levels, since they all provide information about dif-tion marker (Ki-67). In addition, it has been convinc-
ferent diseases, non-uniform time and topological
ingly demonstrated that ascites is an environment
points of sampling of tumor material, or, for exam-
with a very low level of oxygenation since the cells
ple, blood oxygenation. From this point of view, the
floating in it do not have adequate blood supply and
use of animal models allows, as far as possible, to
can survive only through glycolysis pathway. It is im-
bring uniformity to the experimental conditions and
portant to note that the authors mention that tumor
obtain reproducible results by performing serial ex-
hypoxia is a driving factor in resistance to radiation
periments. Considering the listed advantages of the
therapy and chemotherapy [16].
in vivo approach, we performed an experiment to
In this study, a low level of Ki-67 expression was
study the effect of low oxygenation on liver cancer
noted in tumor samples of animals with blood flow
cells. The results of the IHC study showed that in
reduction, however, zoning in the location of positive-
tumor samples of animals with reduced blood flow,
ly colored cells was observed in tumor tissues. Cells
a lower value of the Ki-67 proliferation marker was
expressing Ki-67 were concentrated along the tumor
observed. An analysis of the literature data showed
zones directly in contact with intact liver tissue. It is
that in the works of other authors there is a direct
known that the so-called "invasion front" of a tumor connection between hypoxia and the proliferative
is formed by cells located on its surface, and they
potential of tumor cells. For example, a study of en-
form patterns of invasion and tumor spread. Given
dometrial tumors showed that the expression level
this fact, it can be assumed that cells that have re-
of Ki-67 is inversely correlated with the expression
tained their proliferative potential, despite the effects
level of hypoxia- induced factor (HIF-1a), which in-
of hypoxic conditions resulting from blood flow re-
dicates low cell proliferative activity in conditions
duction, and located along the edge of the tumor
of oxygen deficiency. In addition, such a correlation
node, may have an increased invasive potential. In
may contribute to reducing the effect of anti-cancer
addition, the observed zonality of Ki-67 expression
drugs such as metformin [15]. Also, in the work on
may probably be related to proximity or distance
visualization of hypoxia of cancer cells in animals
from blood vessels with reduced blood flow.
and cancer patients, it was found that tumor cells
in effusions and micrometastases were in a state
CONCLUSION
of high hypoxia and low proliferation, regardless of
the type of tumor. In this work, samples of human
This study shows that liver tumors of mice sub-
and animal tumor cells were examined by IHC for
jected to the liver blood flow reduction procedure
HIF-1a, glucose transporter (GLUT-1) and prolifera-
were characterized by lower Ki-67 values. The ob-
А
Б
Fig. 4. IHC reaction of the tumor to Ki-67 antibodies (clone SP6). A – without reduction of liver blood flow; B – after reduction of liver blood flow by occlusion of the portal triad. Magnification × 200
40
Южно-Российский онкологический журнал 2024. Т. 5, № 2. С. 35-42
Кечерюкова Т. М., Трифанов В. С., Шульга А. А., Гончарова А. С., Гурова С. В., Ульянова Е. П., Максимов А. Ю. Влияние гипоксии на пролиферативную
активность клеток ортотопического ксенографта гепатоцеллюлярной карциномы печени в эксперименте
tained data indicate that the proliferative activity of
and development of malignant tumors may contrib-
tumor cells is directly related to the microenviron-
ute to a deeper understanding of the biological char-
ment, particularly to the hypoxic environment. Fur-
acteristics of tumors and the approaches to their
ther study of the effects of hypoxia on the growth
treatment.
References
1. Semenza GL. Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu Rev Pathol. 2014;9:47–71.
https://doi.org/10.1146/annurev-pathol-012513-104720
2. Fitzpatrick SF. Immunometabolism and Sepsis: A Role for HIF? Front Mol Biosci. 2019 Sep 6;6:85.
https://doi.org/10.3389/fmolb.2019.00085
3. Jing X, Yang F, Shao C, Wei K, Xie M, Shen H, et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019 Nov 11;18(1):157. https://doi.org/10.1186/s12943-019-1089-9
4. Hsieh CH, Lee CH, Liang JA, Yu CY, Shyu WC. Cycling hypoxia increases U87 glioma cell radioresistance via ROS induced higher and long-term HIF-1 signal transduction activity. Oncol Rep. 2010 Dec;24(6):1629–1636.
https://doi.org/10.3892/or_00001027
5. Wu J, Li S, Huang Y, Zeng Z, Mei T, Wang S, et al. MRI features of pituitary adenoma apoplexy and their relationship with hypoxia, proliferation, and pathology. J Clin Ultrasound. 2023;51(6):1078–1086. https://doi.org/10.1002/jcu.23492
6. Dewhirst MW, Ong ET, Braun RD, Smith B, Klitzman B, Evans SM, et al. Quantification of longitudinal tissue pO2 gradients in window chamber tumours: impact on tumour hypoxia. Br J Cancer. 1999 Apr;79(11–12):1717–1722.
https://doi.org/10.1038/sj.bjc.6690273
7. Bristow RG, Berlin A, Dal Pra A. An arranged marriage for precision medicine: hypoxia and genomic assays in localized prostate cancer radiotherapy. Br J Radiol. 2014 Mar;87(1035):20130753. https://doi.org/10.1259/bjr.20130753
8. Kit OI, Derizhanova IS, Karnaukhov NS. Issues on classification of gastric neuroendocrine tumors. Voprosy onkologii.
2016;62(5):573–579. (In Russ.). EDN: WWOQFF
9. Petrillo M, Patella F, Pesapane F, Suter MB, Ierardi AM, Angileri SA, et al. Hypoxia and tumor angiogenesis in the era of hepatocellular carcinoma transarterial loco-regional treatments. Future Oncol. 2018 Dec;14(28):2957–2967.
https://doi.org/10.2217/fon-2017-0739
10. Fei M, Guan J, Xue T, Qin L, Tang C, Cui G, et al. Hypoxia promotes the migration and invasion of human hepatocarcinoma cells through the HIF-1α-IL-8-Akt axis. Cell Mol Biol Lett. 2018;23:46. https://doi.org/10.1186/s11658-018-0100-6
11. Goncharova AS, Gurova SV, Khodakova DV, Kecheryukova TM, Maksimov AYu, Lapteva TO, et al. Modeling of liver hypoxia in an in vivo experiment. Yakut Medical Journal. 2023;(2(82)):5–8. (In Russ.). https://doi.org/10.25789/YMJ.2023.82.01, EDN: WBXQQT
12. Ron A, Deán-Ben XL, Gottschalk S, Razansky D. Volumetric Optoacoustic Imaging Unveils High-Resolution Patterns of Acute and Cyclic Hypoxia in a Murine Model of Breast Cancer. Cancer Res. 2019 Sep 15;79(18):4767–4775.
https://doi.org/10.1158/0008-5472.CAN-18-3769
13. Gurova SV, Kecheryukova TM, Goncharova AS, Kolesnikov EN, Kozhushko MA, Tatimov MZ. Models of liver cancer in vivo.
Modern problems of science and education. 2023;(4):136. (In Russ.). https://doi.org/10.17513/spno.32707, EDN: XFEYBT
14. Kecheryukova TM, Gurova SV, Goncharova AS, Maksimov AYu, Galina AV, Romanova MV, et al. Comparative assessment of methods to create orthotopic model of liver cancer. Modern Problems of Science and Education. 2023;(2):94. (In Russ.).
https://doi.org/10.17513/spno.32565, EDN: ZFJIHU
15. Sivalingam VN, Latif A, Kitson S, McVey R, Finegan KG, Marshall K, et al. Hypoxia and hyperglycaemia determine why some endometrial tumours fail to respond to metformin. Br J Cancer. 2020 Jan;122(1):62–71.
https://doi.org/10.1038/s41416-019-0627-y
16. Li Y, Zhao L, Huo Y, Yang X, Li Y, Xu H, et al. Visualization of hypoxia in cancer cells from effusions in animals and cancer patients. Front Oncol. 2022;12:1019360. https://doi.org/10.3389/fonc.2022.1019360
41
South Russian Journal of Cancer 2024. Vol. 5, No. 2. P. 35-42
Kecheryukova T. M., Trifanov V. S., Shulga A. A., Goncharova A. S., Gurova S. V., Ulyanova E. P., Maksimov A. Yu. Hypoxia effect on proliferative activity of cells in orthotopic xenograft of hepatocellular carcinoma of the liver in the experiment Information about authors:
Takhmina M. Kecheryukova – MD, X-ray physician, endovascular diagnostics and treatment of Abdominal Oncology Department No. 1, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0000-0002-8092-6457
Vladimir S. Trifanov – Dr. Sci. (Med.), Associate Professor, Head of the Abdominal Surgery Center, surgeon, leading researcher of the branch P.
A. Hertsen Moscow Oncology Research Institute – Branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, Moscow, Russian Federation; Leading researcher of the Thoracic-abdominal Department, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
ORCID: https://orcid.org/0000-0003-1879-6978, SPIN: 3710-8052, AuthorID: 453981
Anna A. Shulga – junior researcher at the Testing Laboratory center, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
ORCID: https://orcid.org/0009-0006-1125-2897, SPIN: 6457-4451, AuthorID: 1221869
Anna S. Goncharova – Cand. Sci. (Biol.), Head of the testing laboratory center, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
ORCID: https://orcid.org/0000-0003-0676-0871, SPIN: 7512-2039, AuthorID: 553424, Scopus Author ID: 57215862139
Sophia V. Gurova – junior researcher at the Testing Laboratory center, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
ORCID: https://orcid.org/0000-0002-9747-8515, SPIN: 5413-6901, AuthorID: 1147419
Elena P. Ulyanova – researcher at the Laboratory of Tumor Immunophenotyping National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
ORCID: https://orcid.org/0000-0001-5226-0152, SPIN: 1243-9475, AuthorID: 759154, Scopus Author ID: 57203357998
Aleksei Yu. Maksimov – Dr. Sci. (Med.), professor, Deputy CEO for Advanced Scientific Research, National Medical Research Centre for Oncology, Rostov-on-Don, Russian Federation
ORCID: https://orcid.org/0000-0002-1397-837X, SPIN: 7322-5589, AuthorID: 710705
Contribution of the authors:
Kecheryukova T. M. – conducting an experiment;
Trifanov V. S. – editing the text;
Shulga A. A. – text writing, statistical analysis;
Goncharova A. S. – search for literature data, writing a text; Gurova S. V. – conducting an experiment;
Ulyanova E. P. – histological analysis;
Maksimov A. Yu. – text editing.
42